RISE-YA for Cancer-Related Fatigue in Young Adult Brain Tumor Survivors

This study is looking at how a program called RISE-YA can help young adults (ages 18-39) who have survived a brain tumor and are experiencing cancer-related fatigue. The RISE-YA program includes counseling on how to save energy, coaching on behavior, and exercise training. Participants will also receive survivorship education through video calls. The main goal is to see if RISE-YA can reduce fatigue. Researchers also want to see if it improves physical activity and function, and how it affects certain body processes like inflammation. You may be able to join if you are 18-39, were diagnosed with a brain tumor between ages 15-39, finished curative treatment 6 months to less than 5 years ago, received both chemotherapy and radiation, and have a specific level of fatigue (FACIT-Fatigue score of 43 or less). The study is currently unclear on its recruitment status and plans to enroll 75 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 75 participants.
What's involved
Participants will receive weekly video calls for 12 weeks, with some weeks having one call and others having one call during weeks 7-12. Each video call will last about 60 minutes.
Compensation
Not stated in the trial record.
Follow-up
Safety and adverse events (side effects) will be monitored through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07186556

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

Recruiting
NAAges 18–39InterventionalSupportive care
M.D. Anderson Cancer Center
~75 participants
Updated 2026-08-12 on ClinicalTrials.gov
What's tested:Survivorship EducationRISE-YA Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cancer Related Fatigue
Measured over Measured at T1 (baseline), T2 (12 weeks), and T3 (24 weeks)
Cancer
Fatigue
Brain Tumor Adult
1 sites across 1 states
Texas1
  • Michael Roth, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Cancer Related FatigueMeasured at T1 (baseline), T2 (12 weeks), and T3 (24 weeks)

    To compare changes in cancer related fatigue at T2 and T3 relative to T1 between participants in the RISE-YA intervention and participants in the attention control. Measure: Multi-dimensional Fatigue Inventory. Scores range from 20 to 100, with higher values indicating greater fatigue severity